2026 SPS Denver
Event Ended
This event has ended. Registration is no longer available.
Event Schedule
Event Overview
This program provides pharmacists and pharmacy technicians with advanced education on emerging clinical evidence and evolving pharmacotherapy management strategies across oral and intravenous therapies.
With the rapid expansion of treatment modalities, particularly in oncology, hematology, neurology, and endocrinology, practitioners must stay informed about the latest evidence-based advances influencing precision medicine and individualized patient care.
The summit emphasizes pharmacists critical role in optimizing therapeutic outcomes through effective monitoring, adherence support, and collaboration within the healthcare team.
Participants will explore validated tools for patient monitoring, strategies for improving adherence, and practical approaches for navigating complex specialty drug access pathways.
Expert faculty will also address evolving trends such as biosimilars, 505(b)(2) products, and innovative drug classes focusing on their clinical, operational, and economic implications.
Through discussion of local market dynamics and multi-stakeholder collaboration, attendees will identify opportunities to enhance patient access, efficiency, and value in the specialty pharmacy ecosystem.
Expected attendance: 50 75 participants.
Instructions for Credit
Thank you for attending this conference. Your feedback is valuable to us.
To receive your Certificate of Attendance, complete and submit the Evaluation Form. Once this form is submitted your certificate will be available for download.
Registered attendees can earn a maximum of 8.00 CPE credits. You will be able to select the amount of credits being claimed.
Pharmacists: NABP e-profile number and date of birth (mm/dd/yyyy). Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.
For questions regarding credit for this activity, please contact MEC at info@meccinc.com. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Credits
- AMA PRA Category 1 Credit™8.00
- Pharmacy8.00
Universal Activity Number(s)
Pharmacist: JA4008179-0000-26-004-L04-P
Event Details
- Duration
- 8.00 hours
- Start Date
- May 15th, 2026 7:30 AM (EDT)Central: May 15th, 2026 6:30 AMMountain: May 15th, 2026 5:30 AMPacific: May 15th, 2026 4:30 AM
- End Date
- May 16th, 2026 5:25 PM (EDT)Central: May 16th, 2026 4:25 PMMountain: May 16th, 2026 3:25 PMPacific: May 16th, 2026 2:25 PM
Objectives
At the conclusion of this activity, learners should be better able to:
Evaluate emerging specialty pharmacotherapy options and determine their relevance to patient-specific treatment plans.
Apply evidence-based strategies for therapy management, monitoring, and adherence support in complex disease states.
Implement validated tools and processes to optimize patient adherence and therapeutic outcomes.
Assess opportunities to integrate biosimilars, 505(b)(2) products, and innovative therapies to enhance clinical and operational efficiency.
Develop collaborative strategies among pharmacists, patients, payers, and manufacturers to improve access and value in specialty pharmacy practice.
Target Audience
This continuing pharmacy education activity is designed for pharmacists and pharmacy technicians who provide, manage, or support specialty pharmacotherapy services in a variety of settings, including hospital, clinical, community, and specialty pharmacy practice. The content is appropriate for those involved in patient care, formulary management, and clinical decision-making related to specialty and complex therapies.
Faculty & Disclosure
Faculty
No Faculty or Disclosure
Disclosure
No Faculty or Disclosure
Accreditation
In support of improving patient care, The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacist
This Knowledge-based activity has been approved for 8.0 contact hours (.800) by The Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-0000-26-004-L04-P. Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.
For any profession outside of pharmacy, contact your state or professional licensing board directly to confirm if a specific ACPE-accredited course will be accepted.